Myomo Strengthens Intellectual Property Portfolio with Receipt of Key Patent in Japan

Brings the total number of patents issued on the MyoPro® device globally to 20

BOSTON (February 17, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the granting of patent number 6998478 titled “Powered Orthotic Device and Method of Using Same” by the Japanese Patent Office. Read more.